ICD-10-CM Code For Hyperaldosteronism: Group Overview
The International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) code group E26 includes diagnoses related to excess aldosterone production such as primary and secondary hyperaldosteronism, including conditions caused by adrenal adenomas or bilateral adrenal hyperplasia that lead to hypertension and electrolyte disturbances. These ICD-10-CM diagnosis codes are used to document clinical scenarios involving resistant hypertension, hypokalemia, or adrenal neoplasms and to capture disease severity, organ involvement, and treatment complexity relevant to this group. Accurate coding within the ICD-10-CM E26 group supports proper claim adjudication, complete clinical documentation, and appropriate reimbursement.
Customize your policy alerts
Sign up for ICD-10-CM Code For Hyperaldosteronism: Group Overview policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
ICD-10-CM E26: Hyperaldosteronism Overview
The ICD-10-CM E26 group represents disorders characterized by excess production of aldosterone, primarily affecting mineralocorticoid balance and blood pressure regulation. These diagnoses target the endocrine system, specifically adrenal gland function and its impact on sodium, potassium, and fluid homeostasis. Accurate coding is important for capturing clinical severity and ensuring appropriate reimbursement and longitudinal patient tracking.